{{medical}}
{{Drugbox
| type=vaccine
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447912941
<!-- Vaccine data -->
| target = [[甲型肝炎|甲型肝炎]]
| vaccine_type = <!--Live attenuated, -->killed
<!-- Clinical data -->
| tradename = Biovac A, Havrix, others
| Drugs.com = {{drugs.com|CDI|hepatitis_a_vaccine}}
| MedlinePlus = a695003
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = Safety undetermined, risk likely low
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = Rx-only<!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration = IM
<!-- Identifiers -->
| ATC_prefix = J07
| ATC_suffix = BC02
| PubChem = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| CAS_number = 1704511-91-0
| CAS_number_Ref = {{cascite|correct|CAS}}
<!-- Chemical data -->
}}
<!-- Definition and medical uses -->
'''A型肝炎疫苗'''是用於預防A型肝炎的疫苗<ref name=WHO2012>{{cite journal|title=WHO position paper on hepatitis A vaccines – June 2012.|journal=Wkly Epidemiol Rec|date=2012-07-13|volume=87|issue=28/29|page=261-76|pmid=22905367|url=http://www.who.int/wer/2012/wer8728_29.pdf|access-date=2016-02-21|archive-date=2015-12-16|archive-url=https://web.archive.org/web/20151216090802/http://www.who.int/wer/2012/wer8728_29.pdf|dead-url=no}}</ref>。 對95%的人都會有效，且能持續至少15年以上的效期，很多人甚至能持續一生<ref name="WHO2012" /><ref name=Ott2012>{{cite journal |author=Ott JJ, Irving G, Wiersma ST |title=Long-term protective effects of hepatitis A vaccines. A systematic review |journal=Vaccine |volume=31 |issue=1 |pages=3–11 |date=December 2012 |pmid=22609026 |doi=10.1016/j.vaccine.2012.04.104}}</ref>。幼兒應接種 2 劑，於出生滿 12-15 個月接種第 1 劑，間隔 6 個月以上接種第 2 劑<ref>{{Cite web|url=https://www.cdc.gov.tw/downloadfile.aspx?fid=DCCEEFFB774E612E|title=幼兒A 型肝炎預防接種Q&A - 衛生福利部疾病管制署|accessdate=2018-02-02|author=|date=|publisher=|archive-date=2018-02-02|archive-url=https://web.archive.org/web/20180202071919/https://www.cdc.gov.tw/downloadfile.aspx?fid=DCCEEFFB774E612E|dead-url=no}}</ref>。一般經由[[肌肉注射|肌肉注射]]<ref name="WHO2012" />。

<!-- Recommendations -->
[[世界卫生组织|世界衛生組織]]建議中度流行A型肝炎的區域，都應例行性接種此疫苗<ref name=WHO2012/>。但若在A型肝炎高度流行的疫區，民眾大多在幼年即已獲得免疫力者，則不建議例行施打<ref name=WHO2012/>。 [[美国疾病控制与预防中心|美國疾病管制局]]建議所有幼童和有高風險感染的成人都應施打疫苗<ref>{{cite web|title=Hepatitis A In-Short|url=http://www.cdc.gov/vaccines/vpd-vac/hepa/in-short-adult.htm#who|website=CDC|accessdate=7 December 2015|date=July 25, 2014|archive-url=https://web.archive.org/web/20151210191218/http://www.cdc.gov/vaccines/vpd-vac/hepa/in-short-adult.htm#who|archive-date=2015-12-10|dead-url=yes}}</ref>。

<!-- Safety and formulation-->
A肝疫苗很少引發嚴重的副作用<ref name=WHO2012/>。 15%的孩童和接近50%的成人，注射疫苗處會感到疼痛<ref name=WHO2012/>。大多數的A肝疫苗為死菌疫苗，少數疫苗為減毒疫苗<ref name=WHO2012/>。孕婦或免疫力缺失的患者，並不建議使用減毒疫苗<ref name=WHO2012/>。某些劑型會將A型肝炎和[[乙型肝炎|B型肝炎]]或[[伤寒|傷寒]]疫苗混合<ref name=WHO2012/>。

<!-- History, society and culture -->== 历史 ==
1991年，首款由[[葛兰素史克|葛兰素史克]]研发的肝炎灭活疫苗Havrix经审批上市，在歐洲被核准使用<ref name=":0">{{Cite book|chapter=|url=https://books.google.com/books?id=VWdEAgAAQBAJ&pg=PA212#v=onepage&q&f=false|publisher=Elsevier|date=2012-10-31|isbn=978-1-908818-19-5|language=en|first=Vandana|last=Patravale|first2=Prajakta|last2=Dandekar|first3=Ratnesh|last3=Jain|title=Nanoparticulate Drug Delivery: Perspectives on the Transition from Laboratory to Market|year=|location=|pages=|access-date=2021-02-12|archive-date=2020-05-19|archive-url=https://web.archive.org/web/20200519081651/https://books.google.com/books?id=VWdEAgAAQBAJ&pg=PA212#v=onepage&q&f=false}}</ref><ref>{{Cite journal|title=Hepatitis A: Old and New|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88961/|last=Cuthbert|first=Jennifer A.|date=2001-1|journal=Clinical Microbiology Reviews|issue=1|doi=10.1128/CMR.14.1.38-58.2001|volume=14|pages=38–58|issn=0893-8512|pmid=11148002}}</ref><ref>{{Cite web|title=Evidence based recommendations for use of hepatitis A vaccines in immunization services: Background paper for SAGE discussions|url=https://www.who.int/immunization/sage/meetings/2012/april/1_HepABackground_17Oct_final2_nov11.pdf|accessdate=|date=2011-10-17|publisher=[[世界卫生组织|世界卫生组织]]|language=en|archive-date=2013-10-28|archive-url=https://web.archive.org/web/20131028153100/http://www.who.int/immunization/sage/meetings/2012/april/1_HepABackground_17Oct_final2_nov11.pdf}}</ref><ref name=":1">{{Cite web|title=甲型肝炎疫苗推荐书|url=http://www.pediatricsjournal.org.cn/0803/188-196.htm|accessdate=2021-02-13|author=|date=|format=|work=www.pediatricsjournal.org.cn|publisher=|language=|archive-date=2017-06-04|archive-url=https://web.archive.org/web/20170604161402/http://www.pediatricsjournal.org.cn/0803/188-196.htm}}</ref>。1995年，[[莫里斯·希勒曼|莫里斯·希勒曼]]团队（美国[[默克藥廠|默克药厂]]）研发的甲肝灭活疫苗Vaqta也被核准使用<ref name=":0" /><ref name=":1" /><ref>{{Cite web|title=Hepatitis A: Vaccine Licensed {{!}} History of Vaccines|url=https://www.historyofvaccines.org/content/hepatitis-vaccine-licensed|accessdate=2021-02-09|work=www.historyofvaccines.org|language=en}}</ref><ref>{{Cite journal|title=Maurice Hilleman: Creator of Vaccines That Changed the World|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150172/|last=Tulchinsky|first=Theodore H.|date=2018|journal=Case Studies in Public Health|doi=10.1016/B978-0-12-804571-8.00003-2|pages=443–470|pmc=7150172|access-date=2021-02-09|archive-date=2021-01-17|archive-url=https://web.archive.org/web/20210117040546/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150172/}}</ref><ref>{{cite book|last1=Patravale|first1=Vandana|last2=Dandekar|first2=Prajakta|last3=Jain|first3=Ratnesh|title=Nanoparticulate drug delivery perspectives on the transition from laboratory to market|date=2012|publisher=Woodhead Pub.|location=Oxford|isbn=9781908818195|page=212|edition=1. publ.|url=https://books.google.ca/books?id=VWdEAgAAQBAJ&pg=PA212|access-date=2018-02-01|archive-date=2016-03-05|archive-url=https://web.archive.org/web/20160305021437/https://books.google.ca/books?id=VWdEAgAAQBAJ&pg=PA212|dead-url=no}}</ref>。 A型肝炎疫苗在[[世界衛生組織|世界衛生組織]]的必須藥物清單上，建議所有公衛系統都應該要備齊。<ref name="WHO2015E">{{cite web |url=http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf |title=19th WHO Model List of Essential Medicines (April 2015) |date=April 2015 |accessdate=May 10, 2015 |publisher=WHO |archive-date=2015-05-13 |archive-url=https://web.archive.org/web/20150513043105/http://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf |dead-url=no }}</ref> 在美國，一劑疫苗大約是50到100美金左右。<ref name="Ric2015">{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=314}}</ref>

==參考文獻==
{{reflist|2}}

[[Category:肝炎|Category:肝炎]]
[[Category:世界衛生組織基本藥物標準清單內的疫苗|Category:世界衛生組織基本藥物標準清單內的疫苗]]
[[Category:A型肝炎|Category:A型肝炎]]
[[Category:疫苗接种|Category:疫苗接种]]
[[Category:灭活疫苗|Category:灭活疫苗]]